V-PASE: Virtual Physical Activity Seated Exercise - Phase 2

Sponsor
University of British Columbia (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05724823
Collaborator
Canadian Institutes of Health Research (CIHR) (Other), Michael Smith Foundation for Health Research (Other)
120
1
2
46
2.6

Study Details

Study Description

Brief Summary

This study will determine the acceptability of delivering seated exercises online and if seated exercises can improve balance, mobility, quality of life, and cardiometabolic health in those living with a stroke related mobility impairment.

Participants will be allocated to either a 10-week seated exercise program or a delayed 2-week Boot Camp program. All seated exercises sessions and assessments will be conducted virtually.

Condition or Disease Intervention/Treatment Phase
  • Other: Virtual Physical Activity Seated Exercises (V-PASE)
N/A

Detailed Description

The study will be a virtual 10-week multi-site, assessor-blinded, randomized controlled trial with an embedded qualitative component. The study will be conducted in real time using secure videoconferencing software (Zoom). Participants will be randomized 1:1 to a 10-week Seated Exercise group or a delayed 2-week Seated Exercise Group (Boot Camp). Seated exercise sessions will be delivered and supervised by a trained instructor.

Participants will use their own computer, laptop, or tablet for the zoom sessions. No Zoom sessions will be recorded. Caregivers will be invited to attend each exercise session to provide support and assistance but are not obliged to attend. A caregiver, friend, or family member will be required for each assessment to participate in the study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Assessing a Telehealth Seated Exercise Program on Post-stroke Balance and Mobility: A Mixed-method Design
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2026
Anticipated Study Completion Date :
Dec 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: 10-week group

Will receive a 10-week seated exercise program, occurring 3 times per week. Sessions will be 60 minutes in duration.

Other: Virtual Physical Activity Seated Exercises (V-PASE)
The seated exercise program includes a variety of upper and lower limb strengthening, core strengthening, agility (fast arm and leg movements), and flexibility exercises. Participants will be supervised during each session thru videoconferencing by a trained instructor.

No Intervention: Delayed 2-week group (Boot Camp)

The Boot Camp group will complete a 2-week seated exercise program following the 10-week active trial period.

Outcome Measures

Primary Outcome Measures

  1. 30 Second Sit-to-Stand [Immediately post-intervention (following 10-week trial)]

    Assessment of balance and lower extremity strength.

Secondary Outcome Measures

  1. Timed Up and Go [Immediately post-intervention, and retention (2-months post-intervention)]

    Participants stand up from a chair, walk 3 metres, turn around and then sit back down. The TUG assesses balance, mobility and turning ability

  2. Tandem Stance [Immediately post-intervention, and retention (2-months post-intervention)]

    Measures balance in standing as reported in the Short Physical Performance Battery Protocol

  3. Modified Telehealth Fugl-Meyer [Immediately post-intervention, and retention (2-months post-intervention)]

    The modified virtual Fugl-Meyer assess lower extremity impairments in those with stroke

  4. Stroke Impact Scale [Immediately post-intervention, and retention (2-months post-intervention)]

    A self-reported measure of stroke-related disability. There are 8 domains with each item rated using a 5-point Likert scale, where lower scores mean greater difficulty to complete the item.

  5. Activities-Specific Balance Confidence (ABC) [Immediately post-intervention, and retention (2-months post-intervention)]

    The ABC scale is a 16-item questionnaire where a participant rates their confidence in performing activities from 0% to 100% (higher percentages indicate greater self-efficacy).

  6. Fatigue Severity Scale [Immediately post-intervention, and retention (2-months post-intervention)]

    Questionnaire assessing the impact of fatigue on daily tasks and activities. There are 9 questions, each scored from 1 to 7 (1 = strongly disagree; 7 = strong agreement).

  7. Quality of Life (EQ-5D-5L) [Immediately post-intervention, and retention (2-months post-intervention)]

    The EQ-5D-5L assess self-care, mobility, depression/anxiety, pain, and usual activities. Each is scored with 5 levels (1=no problems, 5=major problems). Overall health on the day is scored from 0% (worst health) to 100% (best health).

  8. Patient Health Questionnaire-4 (PHQ-4) [Immediately post-intervention, and retention (2-months post-intervention)]

    The PHQ-4 focuses on depression and anxiety. Questions are scored from 0 to 3 (0=not at all; 3 = Nearly every day).

  9. Lipid Profiles [Immediately post-intervention, and retention (2-months post-intervention)]

    Blood samples will be collected following a 12-hour over-night fast

  10. Fasting Glucose [Immediately post-intervention, and retention (2-months post-intervention)]

    Blood samples will be collected following a 12-hour over-night fast

  11. 30 Second Sit-to-Stand [Retention (2-months post-intervention)]

    Assessment of balance and lower extremity strength.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Participants must meet the following inclusion criteria:
  • Adult (as defined by Province)

  • Chronic stroke (more than 6 months post-stroke)

  • Ability to stand up from a chair

  • Mobility impairment of lower extremity (requires a walking aid, with or without close supervision)

  • Able to safely engage in exercise and tolerate 60 minutes of exercises

  • Able to communicate in English

  • Have access to a tablet, computer, or laptop with internet and email access

Exclusion Criteria:
Participants will be excluded if they meet any of the following criteria:
  • Participating in formal exercise or rehabilitation activities

  • Participating in > 30 minutes/day of physical activity (moderate intensity)

  • Participating in another study that may affect outcomes to this study

  • Severe loss of vision, hearing, speech (including aphasia) or cognition that would preclude use of a computer/tablet and communication over videoconference software

  • A serious comorbid condition (eg., amputation, Parkinson's disease, active cancer)

  • Clinically diagnosed with acute/chronic illness or other condition which has known physical activity contraindications or limits their ability to complete each experimental condition (i.e., chronic low back pain aggravated by prolonged sitting)

Contacts and Locations

Locations

Site City State Country Postal Code
1 GF Strong Rehabilitation Centre Vancouver British Columbia Canada V5Z 2G9

Sponsors and Collaborators

  • University of British Columbia
  • Canadian Institutes of Health Research (CIHR)
  • Michael Smith Foundation for Health Research

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Janice Eng, Professor, University of British Columbia
ClinicalTrials.gov Identifier:
NCT05724823
Other Study ID Numbers:
  • H22-02549
First Posted:
Feb 13, 2023
Last Update Posted:
Feb 13, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Janice Eng, Professor, University of British Columbia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 13, 2023